The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Matched FES and FDG PET imaging in patients with hormone receptor-positive, HER2+ advanced breast cancer.
 
Natasha Hunter
No Relationships to Disclose
 
Lanell Peterson
No Relationships to Disclose
 
David A. Mankoff
Employment - Trevarx Biomedical (I)
Stock and Other Ownership Interests - ImaginAb; Reflexion Medical; Trevarx Biomedical
Consulting or Advisory Role - GE Healthcare; Philips Healthcare
Patents, Royalties, Other Intellectual Property - Trevarx has license to radiopharmaceuticals (I)
Other Relationship - ImaginAb; Reflexion Medical; Trevarx Biomedical
 
Mark Muzi
No Relationships to Disclose
 
Delphine L. Chen
No Relationships to Disclose
 
Shaveta Vinayak
Consulting or Advisory Role - OncoSec
Research Funding - OncoSec (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
William R Gwin
Consulting or Advisory Role - CoreA Therapeutics
Research Funding - Veana Therapeutics
 
Jennifer M. Specht
Honoraria - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline
Consulting or Advisory Role - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline
Research Funding - Abbvie (Inst); Cascadian Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Merck (Inst); Minerva Biotechnologies (Inst); Myriad Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Seagen (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - GE Healthcare; GlaxoSmithKline; Nektar
 
Hannah M. Linden
Leadership - Evolent (I); Progyny (I)
Stock and Other Ownership Interests - Evolent (I)
Consulting or Advisory Role - GE Healthcare; Novartis; Pfizer; Sanofi
Research Funding - Pfizer (Inst); Sanofi/Aventis (Inst); Tolmar (Inst); Zeno Pharmaceuticals (Inst); Zionexa (Inst); Zymeworks (Inst)